Ben Issitt of Enmore has become the first patient in the south west to be fitted with a brand new type of pacemaker.
17 May 10 -- Ben Issitt of Enmore has become the first patient in the south west to be fitted with a brand new type of pacemaker.
Ben, 22, was fitted with a new Advisa MRI safe pacemaker that means he will be able to have an MRI scan in the future should he need one. This is not possible with an ordinary pacemaker.
“I have been suffering from low blood pressure and blackouts since Christmas, and was rushed into Musgrove by ambulance recently. The operation itself took about two hours and, following extensive tests, was done within two days of my admission. I have a scar at the top of my chest but as the new pacemaker regulates my heartbeat, it makes a big difference; I feel great now. I can’t speak highly enough of the staff, they have all been fantastic,” he said.
Because of Ben’s young age, it is extremely valuable to be able to fit this new type of pacemaker, said Dr. Mark Dayer, a consultant cardiologist at Musgrove Park, who carried out the procedure.
“Patients with pacemakers usually have to have CT scans instead of MRIs. For a young man this could mean a lot of radiation scans over his life, which carries its own risks. The operation went well and Ben went home the next day,” he said.
Ben was the first patient in the south west to receive the new product, which was produced by medical device company Medtronic using an advanced design to protect the pacemaker from the strong magnetic fields of the MRI.
Musgrove Park Hospital is one of the largest pacing centers in the NHS South West and the team perform over 500 pacing procedures each year. Musgrove Park Hospital Taunton is part of Taunton and Somerset NHS Foundation Trust.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.